US 9018251
Method for treating brain cancer or reducing temozolomide-resistance of brain cancer cells
granted A61KA61K31/343A61K31/4188
Quick answer
US patent 9018251 (Method for treating brain cancer or reducing temozolomide-resistance of brain cancer cells) held by China Medical University expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- China Medical University
- Grant date
- Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/343, A61K31/4188, A61K31/495, A61P